Mitochondrial protein synthesis involves an intricate interplay between mitochondrial DNA encoded RNAs and nuclear DNA encoded proteins, such as ribosomal proteins and aminoacyltRNA synthases. Eukaryotic cells contain 17 mitochondria-specific aminoacyl-tRNA synthases.
INTRODUCTION
Aminoacylation of tRNAs plays a key role in both cytosolic and mitochondrial (mt) protein synthesis, and requires aminoacyl-tRNA synthases (aaRS). Eukaryotic cells contain 37 different aaRS proteins, of which the 17 so-called mt-aaRS proteins (encoded by aaRS2 genes) are exclusively localized in mitochondria. Biallelic variants in 16 of the genes encoding the mitochondrial aaRS2 proteins have already been reported with a clinical phenotype (Almalki et al., 2014; Dallabona et al., 2014; Nishri et al., 2016; Vanlander et al., 2015) . Very recently, WARS2 (MIM# 604733) encoding tryptophanyl-tRNA synthase (mtTrpRS), a homodimeric class Ic mt-aaRS enzyme, was reported as a candidate gene in two single case reports (Musante et al., 2017; Theisen et al., 2017) . Here, we report six individuals from five families ( Figure 1 ) and define the clinical, neuroradiological, and metabolic phenotype of mtTrpRS deficiency, confidently implementing WARS2 as a disease gene involved in mitochondrial disease.
MATERIAL AND METHODS
Case reports are summarized in Table 1 . All procedures followed were in accordance with the Helsinki Declaration, and all parents gave written informed consent (2013).
Family 1, Individual I1: Individual 1 was born as second child (female) of healthy parents from a closed Slowakian community in Serbia.
Cesarean section was performed in the 38th gestational week due to intrauterine growth restriction. Birth weight was 1,240 g, length 38 cm, head circumference 29 cm (all p < 5), APGAR scores were 6 and 8 at 1 and 5 min respectively; she was transferred to the neonatal intensive care of a tertiary referral center. Lactate was 21 mmol/l (normal range [NR] < 2 mmol/l); there were no laboratory signs suggestive for sepsis, and TORCHES, glucose, liver function tests (LFT), coagulation tests, and ammonia were within NR. Brain, abdominal, and heart ultrasound were unremarkable. Due to a distended abdomen, the abdominal cavity was explored, showing dilated loops of the small intestines and air and meconium filled colon. There were no signs of obstruction nor perforation; an ileostomy was performed.
Amino acids in plasma were within the NR values with exception of clearly elevated alanine 720 Family 2, Individual 2 and I3: Individual 2 (male) was born at term as first child to healthy, unrelated Dutch parents after an uneventful pregnancy (birth weight 2,680 g (p5-10), APGAR scores 3 and 9 after 1 and 5 min). From the second day of life, progressive tachypnea was noted; he displayed a lactic acidosis (max. 23.2 mmol/l, NR < 2.2 mmol/l) and a hypoglycemia (1.5 mmol/l [NR > 2.6]). The next day he was transferred to a tertiary center and lactate levels decreased to 2.7-6 mmol/l under high amounts of i.v. glucose (up to 10 mg/kg/min). He was discharged at day 30.
The repetitive lactate measurements in the next months were higher in fasted (max. 5.6 mmol/l) than in fed state (max. 4.2 mmol/l).
At the age of 9 months, he was diagnosed with West syndrome. His development was globally delayed. He had frequent periods where he cried, was hypertonic, and presented dystonic movements. Due to the need of frequent feeds and his impaired swallowing, he received tube feeding. MRI at age 19 months showed subcortical hypointensive white matter lesions in the pre-and post-central gyrus and in the center semiovale going along with absent myelinization. No evident petechial cortical bleedings (as seen in hypoglycemia) were present.
MRS of the cranial regions of the lateral ventricles showed (aspecifically) elevated choline with normal N-acetylaspartate and absent lactate, arguing against hypoxia. At the age of 3.5 years, he died from respiratory insufficiency probably following a viral infection.
Individual 3 (male) was the younger brother of I2. The pregnancy was complicated by intrauterine growth retardation. A cesarean section was performed at 34 +1 weeks of gestation due to fetal distress.
Birth weight was on p10, APGAR scores were 9 after both 1 and 5 min.
A few hours after birth, blood lactate levels reached 11.2 mmol/l and blood glucose was in the lower NR (2.4 mmol/l) without clinical signs.
He was first treated with high i.v. glucose (10 mg/kg/min) on which lactate concentrations normalized. Cerebral ultrasound in the first week was normal and cerebral MRI in the third week of life showed edema of the white matter and elevated lactate in all voxels measured on MRS.
He was discharged after 1 month. At the age of 3 months, his suckling reflex had disappeared and he was started on drip feeding. He seemed to have stopped with any development; neurological examinations showed generalized muscular hypotonia and brisk tendon reflexes. A follow-up MRI at the age of 18 months showed marked frontal cortical and subcortical atrophy; the MRS was unchanged. Shortly after, he died after an epileptic seizure. Family 3, Individual I4: Individual I4 (female) was born as first child at term after an uneventful pregnancy to healthy, unrelated French parents. Delivery, anthropometrics at birth, and neonatal course were unremarkable. At the age of 4 months, she presented muscular hypotonia and strabismus; at the age of 6 months, she was diagnosed with West syndrome. At that time also, global developmental delay and retinitis pigmentosa were noted. At the age of 1 year, she developed cardiomyopathy. At the age of 3 years, she died in an epileptic seizure.
Lactate levels and LFT were not reported. An MRI was not available. coagulation tests, and serum lactate levels were unremarkable (0.9-1.5 mmol/l), as were urinary and CSF lactate. Urinary organic acids and plasma amino acids were unremarkable. CK was intermittently elevated up to 1,000 U/l (NR < 250 U/l).
Family 5, Individual I6: Individual I6 (female) was born at 37 weeks of gestation as first child to healthy unrelated Canadian parents by cesarean section due to fetal distress. Pregnancy, anthropometrics at birth, and neonatal course were unremarkable. At the age of 18 months, she was presented with delayed speech and fine motor skills.
A mild ataxia and weakness of the left arm and leg with mild spasticity were noted. She did not walk independently until the age of 7.5 years; and currently, at the age of 10 years, she can only walk very short distances using a walker due to severe ataxia. She has mild to moderate intellectual disability, mild optic atrophy (but no apparent visual impairment) and nystagmus, severe ataxia, spastic legs (left more than right), and rigidity of her arms and legs. Lactate was first measured at the age of 18 months and was 2.9 mmol/l (NR < 2.0), and has varied between mildly elevated and normal over the years. LFT, bilirubin, glucose, and coagulation studies were normal. MRI examinations performed at the age of 18 months and 4 years showed mild cerebral volume loss and mild cerebellar volume loss, respectively.
Mitochondrial oxidative phosphorylation (OXPHOS) enzymes measurements were performed as described previously (Feichtinger et al., 2014; Janssen, Smeitink, & van den Heuvel, 2003; Rodenburg, 2011; Rustin et al., 1994) .
Whole exome sequencing (WES) was initiated independently at three different centers on leukocyte derived DNA of I1, I2, I4, I5, I6 following previously described procedures (Kremer et al., 2016; Neveling et al., 2013; Wortmann, Koolen, Smeitink, van den Heuvel, & Rodenburg, 2015) . Based on the suspected autosomal recessive pattern of inheritance, we prioritized genes carrying biallelic variants. For each individual, common variants were filtered out based on a minor allele frequency of <1% in dbSNP (v.137), the Genome Aggregation Database (gnomAD) (Lek et al., 2016) , and the respective in-house databases.
The effect of the missense variants identified in mtTrpRS was evaluated by using a mtTrpRS homology model, which was constructed using PDB file 1i6l as a template. This PDB file contains the structure of mtTrpRS from Geobacillus stearothermophilus complexed with tryptophanyl-5 ′ AMP. This sequence shares 44% sequence identity with human mtTrpRS. The YASARA (Krieger, Koraimann, & Vriend, 2002) and WHAT IF Twinset (Vriend, 1990) were employed (with default parameters) for model building and subsequent analyses.
For Western blot analysis, a total of 20 g of mitochondrial protein extract prepared from fibroblasts of two controls (C1, C2) and two affected individuals (I1, I5) were loaded on a 10% SDS gel. After separation, proteins were blotted on a nitrocellulose membrane (Feichtinger et al., 2014) . (m/z = 445.12) was used for internal calibration (Olsen et al., 2005) . The analysis of the RAW files was performed using the MaxQuant software package (version 1.5.0.25, www.maxquant.org) (Cox & Mann, 2008) .
Extracted spectra were matched against the reviewed H. sapiens NCBI RefSeq database release 71. Sequences of known contaminants were added to this database and the reverse decoy was strictly set to FDR of 0.01. Database searches were done with 20 ppm and 0.5 Da mass tolerances for precursor ions and fragmented ions. Trypsin with the allowance of two missed cleavages was selected as the protease. Modifications were set as N-terminal acetylation and oxidation of methionine for dynamic modifications and cystein carbamidomethylation as a fixed modification. Protein abundancies were determined by label-free quantitation using the composite iBAQ intensity values determined by MaxQuant (Jia et al., 2002) . The abundance of mtTrpRS 37.9 kDa isoform 1 (NP_056651.1) as iBAQ intensity was normalized to total iBAQ intensity of the voltage-dependent anion-selective channel protein 1 (VDAC1; NP_003365.1) to adjust for protein differences in the analyzed mitochondrial samples.
tRNA aminoacylation assay was performed using total RNA isolated from patient fibroblast cells grown to subconfluent monolayer using Hybridization probes were generated by in vitro transcription by T7
RNA polymerase in the presence of 32 P-labeled alpha-UTP, using linearized templates. The respective constructs were generated by PCR using mitochondrial DNA as starting material and forward and reverse primers for the mitochondrial tRNA Trp and tRNA Arg genes (Supp . Table   S1 ; T7 RNA polymerase promoter sequence in the reverse primer).
RESULTS
Based on the multisystem involvement in combination with an elevated lactate, a mitochondrial disorder was suspected. The individuals showed a varying degree of abnormalities in the mitochondrial oxidative phosphorylation (OXPHOS) enzymes (Supp . Table S1 ). Mild enzyme deficiencies were observed in muscle tissue of I6 and in both muscle tissue and fibroblasts of I4, while the clinically most severely affected patient I1 showed severe combined complex I and IV deficiency in liver tissue but normal amount in muscle tissue (Figure 2 ). In muscle tissue of I3 and fibroblasts of I1-I3, no significant abnormalities of OXPHOS enzymes were observed (Supp . Table S1 ).
With WES WARS2 (NM_015836.3, MIM# 604733) biallelic variants were prioritized in all five index cases. A total of six different missense mutations, one frameshift mutation, and one insertion/deletion were detected (Figure 1 and Supp. Table S2 ). Sanger sequencing confirmed variants in all individuals, as well as an additional affected family member (I3), and carrier status in available parents. In our collective, the variants were spread throughout the entire gene. One of the variants was found in two independent families but there were no hotspot regions. All missense variants affected evolutionary conserved residues (Figure 1 ). No other rare variants were detected in known disease-associated genes or in genes encoding proteins with a mitochondrial location. All variants have been reported to the LOVD database (https://www.lovd.nl/WARS2). Figure   S1A -G).
The Western blot analysis showed the absence of mtTrpRS protein in fibroblasts of I1 and the diminished content in I4 ( Figure 4A ).
Quantification of the Western blot results ( Figure 4B -G) showed very little differences in the expression levels of several subunits of OXPHOS enzyme complexes, with exception of complex IV subunit COX2 encoded by MT-CO2 that appeared moderately reduced ( Figure 4C ).
Next, we investigated the effect of the WARS2 genetic variants on the expression of the mtTrpRS protein by SDS-PAGE and mass spectrometry in fibroblasts of individuals I2 and I3 and a muscle biopsy of individual I2 using the same protocol. Despite the presence of protease inhibitor during sample preparation, the mtTrpRS peptides were hardly detectable around the expected size of 38 kDa, but rather spread over a wide mass rage. We concluded that the WARS2 mutations present in individuals I2 and I3 rendered the mtTrpRS protein more prone to proteolysis ( Figure 4H ). On the basis of the total amount of mtTrpRS peptides detected in the different gel slices, the residual mtTrpRS expression levels in individuals I2 and I3 were calculated to be around 7% in fibroblasts (I2 and I3) and 6% in muscle (I2), compared with the levels in healthy control samples (Supp. Figure S2 
DISCUSSION
Since the discovery of (DARS2) in 2007 (Scheper et al., 2007) , disease causing variants have been discovered in all 17 genes encoding mitochondrial tRNA synthases. For some of these genes, initial reports suggested an association with a distinct clinical phenotype. However, with the identification of an increasing number of individuals with mutations in these genes, it has become apparent that the clinical spectrum associated with a number of these genes (e.g., AARS2 , NARS2 (Vanlander et al., 2015) , RARS2 (Nishri et al., 2016) , FARS2 (Almalki et al., 2014) ) is broader than initially thought. The same holds for WARS2-related mitochondrial disorder as shown here in the six individuals presenting with a disease spectrum ranging from Overview of the missense variants described in this report, in the three-dimensional structure of the mtTrpRS dimeric protein (one subunit is indicated in gray, the other in green). The amino acid changes are indicated in red. The ligand mt-tRNA Trp is indicated in yellow. Detailed images and descriptions of the predicted effects of all variants are included in the supplementary data (Supp. Figure S1A -G) test this assumption at the moment. The data were normalized to the abundance level of the mitochondrial outer membrane protein VDAC1. The overall detectable amounts of mtTrpRS in individuals I2 and I3 were 7% for fibroblasts and 6% for muscle tissue compared to control expression levels Aminoacylation was found to be decreased and mtTrpRS protein levels were found to be severely diminished in patient-derived cells.
Similar observations have been made for defects in other mt-aaRS related mitochondrial disorders Konovalova & Tyynismaa, 2013 and NARS2 (Simon et al., 2015) , and could indicate that the residual mt-aaRS activity and accompanying low levels of tRNA aminoacylation are still sufficient to generate normally functioning OXPHOS enzymes in a tissue-specific manner.
In conclusion, our study shows a broad spectrum of clinical, neuroradiological, metabolic, and biochemical phenotypes in individuals with WARS2 deficiency. It can be assumed that most of these patients will be identified by genetic screening approaches like exome sequencing.
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